Paratek Pharmaceuticals, Inc. (PRTK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.9300 |
| Open | 1.9200 |
| Bid | 1.9000 x 900 |
| Ask | 2.2600 x 800 |
| Day's range | 1.8900 - 1.9800 |
| 52-week range | 1.6000 - 7.0200 |
| Volume | |
| Avg. volume | 733,612 |
| Market cap | 98.37M |
| Beta (5Y monthly) | 1.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.0970 |
| Earnings date | 22 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 31 Oct 2014 |
| 1y target est | 18.50 |
- Simply Wall St.
Even after rising 25% this past week, Paratek Pharmaceuticals (NASDAQ:PRTK) shareholders are still down 89% over the past five years
It's nice to see the Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) share price up 25% in a week. But that doesn't...
- Motley Fool
Paratek Pharmaceuticals (PRTK) Q1 2022 Earnings Call Transcript
Participants on today's call are Evan Loh, M.D, chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer. Michael Bigham, executive chairman, and I will also be available for questions.
- Simply Wall St.
Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) Profit Outlook
We feel now is a pretty good time to analyse Paratek Pharmaceuticals, Inc.'s ( NASDAQ:PRTK ) business as it appears the...
© 2022 Yahoo. All rights reserved.
